The Drugs (Fifth Amendment) Rules, 2026, notified as G.S.R. 477(E) on 9 June 2026, omit the word 'Syrups' from Schedule K of the Drugs Rules, 1945. The Health Ministry announced the change on 16 June 2026.
Schedule K, Serial No. 13, item 7 used to read 'Syrups, lozenges, pills and tablets for cough'. Lozenges, pills and tablets for cough keep the exemption; syrups do not.
The exemption had let shops without a drug licence sell these household remedies in villages of under 1,000 people. Syrups must now be sold only through licensed drug outlets.
The draft was published as G.S.R. 927(E) in December 2025, and the Drugs Technical Advisory Board (DTAB) was consulted before the final rule.
The change follows the deaths of children from cough syrup contaminated with diethylene glycol in Madhya Pradesh and Rajasthan in 2025.
Schedule K lists classes of drugs exempted from parts of Chapter IV of the Drugs and Cosmetics Act, 1940. Serial No. 13 lets unlicensed shops in villages of under 1,000 people sell listed household remedies such as cough lozenges.
Simple Analogy: A short list of items the village grocer may sell without a chemist's licence.
Parent law on import, manufacture, distribution and sale of drugs and cosmetics. Chapter IV covers manufacture, sale and distribution. Section 5 sets up the DTAB and Section 7 the Drugs Consultative Committee
Classes of drugs exempted from specified provisions of Chapter IV and the rules under it. The 2026 amendment takes syrups out of Serial No. 13
The amending notification of 9 June 2026, made by the Central Government after consulting the DTAB
| Schedule | What it covers |
|---|---|
| Schedule H | Drugs to be sold by retail only on the prescription of a Registered Medical Practitioner |
| Schedule H1 | Certain antibiotics, anti-TB and habit-forming drugs; each sale is entered in a separate register kept for three years |
| Schedule X | Psychotropic and habit-forming drugs under the tightest sale and record controls |
| Schedule K | Classes of drugs exempted from certain provisions of Chapter IV |
| Schedule M | Good Manufacturing Practices; revised version notified on 28 December 2023 |
National drug regulator: approves new drugs and clinical trials, sets standards, controls imported drugs and coordinates with state drug controllers
Statutory board that advises the Central and state governments on technical matters under the Act
Advises the Centre, the states and the DTAB on securing uniform administration of the Act across India
WHO alert on four Maiden Pharmaceuticals syrups linked to the deaths of about 70 children in The Gambia
Marion Biotech syrups linked to child deaths in Uzbekistan
Revised Schedule M on Good Manufacturing Practices notified
At least 23 children die in Chhindwara, Madhya Pradesh, after taking Coldrif syrup made by Sresan Pharmaceuticals of Tamil Nadu, which carried diethylene glycol far above the limit
Draft rule G.S.R. 927(E) to drop syrups from Schedule K published for objections
Final rule G.S.R. 477(E) notified
Health Ministry announces the change
GS Paper 2 > Health; statutory and regulatory bodies
General Awareness > Health regulation and Acts
General Awareness > Current national events
Schedule to the Drugs Rules, 1945 listing drug classes exempted from certain provisions of Chapter IV of the Act.
A toxic industrial solvent that can contaminate glycerine or propylene glycol used in syrups and causes acute kidney failure.
Statutory technical advisory board under Section 5 of the Drugs and Cosmetics Act, 1940.
A medicine sold without a prescription. Indian drug law has no formal OTC schedule.